May 13, 2019
Transgene gets FDA IND clearance to start clinical trial of myvac for ovarian cancer treatment
Transgene can start linical trial of its lead myvac™ candidate TG4050as a potential treatment for ovarian cancer patients after first-linesurgery and chemotherapy